Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Erasmus MC - Sophia
Woman and Man Max 99 years
Erasmus MC - Sophia Children's Hospital
Update Il y a 4 ans
Study to look at the usefulness of an extra dose of salbutamol (medicine that widens the airways in the lungs) through the bloodstream, in children who are admitted to an intensive care for a very severe asthma-attack. Een studie om te kijken of het nuttig is om een extra dosis salbutamol te geven (medicijn dat de luchtwegen wijder maakt in de longen) via het bloed, bij kinderen die op een intensive care liggen voor een heel ernstige astma-aanval
To assess the efficacy of a loading dose of intravenous salbutamol in children admitted to a PICU for severe acute wheeze or severe acute asthma. Efficacy is measured by the reduction in asthma score ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Erasmus MC - Sophia Children's Hospital
Update Il y a 4 ans
Protein and Energy Interactions in Critically Ill Children
To assess insulin sensitivity and the effect of protein nutrition and insulin in critically ill children
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Erasmus MC - Sophia
Update Il y a 4 ans
Early introduction in the Netherlands of alglucosidase alfa manufactured in a 4000 liter bioreactor
To evaluate the safety of alglucosidase alfa manufactured in a 4000 liter bioreactor and to transition Dutch patients safely and gradually from alglucosidase alfa manufactured in a 2000 liter bioreact...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Erasmus MC - Sophia
Update Il y a 4 ans
Microdosing midazolam in children: age-related changes in absorption of oral drugs
To describe the total apparent CYP3A mediated clearance (Cl/F) of midazolam in the paediatric intensive care population from the age of 0 to 6 years, as surrogate marker of intestinal and hepatic CYP3...
Country
None
organs
None
Specialty
None
unknown
More information